TABLE 5. Performance Measures Considering the XR Projection (PA/AP).
Experiment | Class | PA | AP | ||||
---|---|---|---|---|---|---|---|
PPV | Recall | F1 | PPV | Recall | F1 | ||
Exp. 1 | Pneumonia | 91.25 ± 1.22 | 92.78 ± 1.58 | 92.00 ± 0.93 | 94.70 ± 0.79 | 96.28 ± 1.10 | 95.48 ± 0.50 |
Control | 98.54 ± 0.33 | 97.83 ± 0.23 | 98.18 ± 0.14 | 97.87 ± 0.28 | 95.46 ± 0.87 | 96.65 ± 0.43 | |
COVID-19 | 84.06 ± 3.94 | 88.91 ± 2.31 | 86.33 ± 1.80 | 95.13 ± 2.46 | 97.18 ± 0.94 | 96.12 ± 1.06 | |
Exp. 2 | Pneumonia | 81.77 ± 1.79 | 79.17 ± 2.38 | 80.41 ± 1.16 | 87.39 ± 1.66 | 90.78 ± 1.21 | 89.03 ± 0.71 |
Control | 94.81 ± 0.46 | 95.56 ± 0.61 | 95.33 ± 0.16 | 92.79 ± 1.53 | 88.15 ± 1.61 | 90.38 ± 0.32 | |
COVID-19 | 73.72 ± 2.37 | 68.82 ± 5.20 | 71.01 ± 2.27 | 84.96 ± 2.27 | 87.63 ± 2.04 | 86.23 ± 0.86 | |
Exp. 3 | Pneumonia | 84.07 ± 1.72 | 87.19 ± 1.66 | 85.57 ± 0.53 | 87.39 ± 0.97 | 81.66 ± 1.12 | 89.47 ± 0.41 |
Control | 97.88 ± 0.36 | 97.08± 0.21 | 97.48± 0.19 | 96.03 ± 0.81 | 90.65 ± 0.87 | 93.26 ± 0.47 | |
COVID-19 | 66.68 ± 4.82 | 65.23 ± 4.73 | 65.61 ± 1.05 | 81.82 ± 3.07 | 83.62 ± 2.14 | 82.65 ± 1.28 |